Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Derm > Hyperpigmentation > Flashcards

Hyperpigmentation Flashcards

You may prefer our related Brainscape-certified flashcards:
Dermatology Board Prep flashcards
1
Q

Top 6 inflammatory causes of PIH

A 
Acne
Atopic dermatitis
Impetigo
Insect bites
LSC
TNPM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Associations with ashy dermatosis

A
  • Infectious: HIV, whipworm
  • Medications: benzodiazepine, penicillins, oral x-ray contrast media, ammonium nitrate
  • Endocrinopathies: thyroid disease
  • Chemicals: exposure to pesticides, fungicides, toxins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is ashy dermatosis different to LPP

A

Ashy dermatosis: cleavage lines, has erythematous border, trunk most commonly, slate-gray to blue brown
LPP is sun exposed: forehead, temples, neck, intetriginous zones, no erythematous border
The histo is different too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of melasma

A

Epidermal
Dermal
Mixed
Indeterminate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical presentation of melasma

A
  1. Centrofacial - forehead, cheeks, nose, upper lip, chin but spares the philtrum and nasolabial folds
  2. Malar: cheek and nose
  3. Mandibular: along the jawline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Riehl melanosis

A

Pigmented contact dermatitis - dermal melanin depositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topical treatment for melasma - the combination treatment

A

4% HQ + kojic acid 4% + tranexamic acid 4% + hydrocortisone 4% (what katie uses) + tretinoin 0.025%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tranexamic acid CI and A/E and dosage

A
  • CI: stroke, spontaneous abortion, smoking, cancer, cardiovascular
  • A/E: headaches, menstrual irregularity, nausea
    250 mg BD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common drugs that cause hyperpigmentation

A 
Chemo: bleomycin, cyclophosphamide, 5-FU, hydroxyurea, MTX
Anti-malarials: chloroquine, quinacrine, hydroxychlorquine
Heavy metals: arsenic, gold, iron
Hormones: OCP, afemalotide
Other:
amiodarone
clofazamine
Diltiazem and amlodipine
Hydroquinone
Minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Minocycline induced hyperpigmentation

A

Type 1: blue-black discolouration in sites of inflammation and scars, including acne or ablative laser
Type 2: blue-gray macules/patches (1mm-10 cm) within previously normal skin, most often on the shin, sometimes misdiagnosed as ecchymoses
Type 3: diffuse, muddy brown pigment most prominent in sun exposed areas
Blue-black discolouration may also involve nails, sclerae, oral mucosa, bones, thyroid and teeth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ochronosis

A

From hydroquinone
Hyperpigmentation in areas of application due to ICD or exogenous ochronosis - latter can produce small, caviar like papules
In ochronosis: yellow-brown banana-shaped fibres in the papillary dermis
Metabolism of melanocytes of hydroquinone into ringed structures that serve as precursors of ochronotic fibres. May fade upon discontinuation of hydroquinone, variable improvement with lasers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dilitazem and amlodipine induced hyperpigmentation

A

Slate gray to gray-brown discolouration of sun-exposed skin in patients, peri-follicular accentuation, and a reticular pattern may be observed.
Sparse lichenoid infiltrate and numerous dermal melanophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clofazimine induced hyperpigmentation

A

Diffuse red to red-brown discolouration of skin, conjunctivae. Violet-brown to blue-gray discolouration, especially of lesional skin.
Red colour secondary to drug in fat, blue-violet colour secondary to brownish granular pigment within dermal macrophages.
EM: phagolysosomes contain amorphous granular material and lamellar structures, characteristic of lipofuscin.
Fades gradually after discontinuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amiodarone induced pigmentation

A

Slate-gray to violaceous discolouration of sun exposed skin, face.
Occurs in fair-skinned patients after long-term, continuous therapy.
On histo yellow-brown granules in dermal macrophages, mostly in a perivascular distribution.
By EM, lysosomal inclusions composed of a lipid-like substance. Usually fades completely over months to years after finishing the drug, but sometimes it can persist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arsenic cutaneous signs

A

PPK
SCC
Arsenic
Bronze hyperpigmenation, can have superimposed raindrops of lightly pigmented skin. Axillae, groin, palms, soles, nipples and pressure points.
Appears 1-20 years after arsenic exposure.
Palmoplantar keratoses and SCC
Dermal and epidermal deposition of arsenic, increased epidermal melanin synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chloroquine, hydroxychloroquine, quinacrine hyperpigmentation

A

Gray to blue-black pigment, usually pre-tibial with HCQ.
Face, hard palate, sclerae and subungual areas.
Quinacrine: diffuse yellow to yellow-brown discolouration
Discolouration affects up to 25% of patients
Dermal deposition of melanin-drug complexes, haemosiderin around capillaries. May fade after discontinuation of drug, but rarely resolves completely.

17
Q

5-FU Hyperpigmentation

A

5-FU
Hyperpigmentation in sun-exposed areas - ~5% of patients treated systematically, often follows an erythematous photosensitivity reaction
Increased pigmentation over skin in which vein had been infused
Also includes dorsal aspects of hands, palms/soles and radiation ports
Transverse of diffuse melanonychia, lunular pigmentation
Leaves PIH

18
Q

Cyclophosphamide hyperpigmentation

A

Diffuse hyperpigmentation of skin and mucous membranes, Transverse, longitudinal or diffuse melanonychia, and pigment can be on palms, soles or teeth.
Usually regresses 6-12 months after therapy has discontinued

19
Q

Ddx for diffuse hyperpigmentation

A 
With sclerodermoid: SScl, POEMS, PCT
Medication induced
Hyperthyroidism
Haemochromatosis
Addison disease, Cushing
Renal disease
Nutritional: pellagra, B12 deficiency, folate deficiency, malabsorption
At birth: CAH, carbon baby syndrome, familial diffuse melanosis
20
Q

Where are pigmentary demarcation lines

A
  • Anterolateral portion of the upper arm
    • Posteromedial aspect of thighs
    • Upper chest
    • Paraspinal region of the back
    • Face
21
Q

Ddx for linear hyperpigmentation

A 
Blaschkoid:
Inherited:
- IP third stage
- Linear and whorled naevoid hypermelanosis
- Goltz syndrome
- McCune albright
- Epidermal naevus
- Conradi Hunermann
Acquired
- Linear LP
- LPP
- Ashy dermatosis
- Linear atrophoderma of Moulin
- PIH due to Blaschkitis

Non-blaschkoid:

  • Flagellate erythema
  • Phytophotodermatitis
  • Linear nigra
  • Linear PIH
22
Q

Flagellate erythema of bleo

A

1-9 weeks after starting

  • Circumscribed: typically over the joints or in other pressure points, but hyperpigmentation can be localized to the palmar creases, striae or sites of adhesive electrode pads
  • Occurs after cumulative doses of 100-300 mg, however has been as low as 15-30 mg (following wart injection etc)
  • Some patients have pruritus or linear urticarial lesions preceding the pigmented streaks, but some people have no itch
  • Brown, commonly on chest and back
  • Other cutaneous findings with bleomycin:
    • Painful nodules on fingers
    • Verrucous plaques on knees and elbows
    • Sclerodermoid changes
    • Digital gangrene due to Raynauds
    • Nails: melanonychia, Beau’s lines, onychomadesis, onycholysis
23
Q

Flagellate erythema of mushrooms

A
  • Pruritic erythematous papules, vesicles and oedema on face, scalp, trunk and extremities
  • 1-2 days post ingestion
  • Scratching –> long, flagellate streaks composed of erythematous papules and/or petechiae on the extremities and the trunk, sparing the mid-upper back
  • Can be followed by a linear pattern of either discolouration due to haemosiderin or PIH
  • Diffuse erythema and oedema in photoexposed areas have been observed in half of Japanese patients, with shiitake mushroom dermatitis
  • Fever and malaise are also associated
24
Q

Linear and whorled naevoid hypermelanosis extra-cutaneous features

A
  • Extra-cutaneous: 10-25%
    • Neurologic
    • Musculoskeletal
    • Cardiac (less often)
      Dental
      Ocular
      Dysmorphism
25
Q

Ddx for reticulate hyperpigmentation

A 
Not genetic
CARP
Prurigo pigmentosa
Erythema ab igne
Pityriasis
Atopic dirty neck
Drug induced

Genetic:

  • Dyskeratosis congenita
  • Dowling Degos
  • Galli Galli
    • others
26
Q

Prurigo pigmentosa associations and clinical

A

Pathogenesis

  • Ketotic states: diabetes, fasting, post-bariatric
  • Systemic diseases: Sjogren
  • Eating disorders: anorexia nervosa
  • Described in atopy and pregnancy too

Clinical

  • Pruritic erptuion of erythematous papules and papulovesicles on back, neck and chest
  • Crops of inflammatory lesions develop rapidly and then involute within a week leaving macular reticulated hyperpigmentation
  • Recurrences occur at same site
  • Lesions in multiple stages are evident
27
Q

Prurigo pigmentosa histology

A

Stages:

  1. Neutrophilic: Neutrophilic exocytosis, spongiosis, papillary dermal oedema, superficial perivascular neutrophilic infiltrate
  2. Eosinophilic: Intra or subepidermal vesiculation, necrotic keratinocytes, patchy lichenoid infiltrate of predominantly lymphocytes admixed with eosinophils
  3. Variable parakeratosis, acanthosis, hyperpigmentation of epidermis as well as dermal melanophages
28
Q

Prurigo pigmentosa treatment

A
  • Oral minocycline, doxycycline, or dapsone –> neutrophilic seems to work
  • Doesn’t respond to topical steroids
29
Q

Triad for dyskeratosis congenita

A

Genetically heterogeneous disorder caused by defective telomere maintenance. Characterised by progressive bone marrow failure, and triad of:

  1. Reticulated hyperpigmentation
  2. Nail dystrophy
  3. Leukoplakia
30
Q

Dyskeratosis congenita epidemiology

A
  • Most common: X-linked recessive
  • Can be autosomal dominant and recessive
  • M>F 3:1
    DKC1 mutation + others
31
Q

Dyskeratosis congenita clinical

A 
DYSKERATOSIS
Dicks and dominant
Y
Skeletal: bone marrow failure
K
Epiphora: continueous lacrimation
Resp: fibrosis, liver cirrhosis
Avascular necrosis fo the femoral head
Tumours: SCC, myelodysplastic syndrome, AML, GI cancers
Oesophageal or urerthral senosis
Short stature, developmental delay
Immunologic dysfunction leading to opportunistic infection
Sweating - hyperhidrosis, hyperkeratosis
Cutaneous: hyperpigmentation
Oral leukoplakia
Nail dystrophy: pterygia
Graying of hair prematurely
E
N
I
Telangiectasia – poikiloderma atrophicans vasculare
Acrocyanosis

Clinical

  • Cutaneous:
    • lacy, reticulated pattern of hyperpigmentation in the first decade of life. This occurs to neck, upper chest, and upper arms, sometimes with macules of hypopigmentation
    • Telangeictasia and epidermal atrophy –> poikiloderma atrophicans vasculare
    • Wrinkled skin on the extremities, dorsal aspects of hands and genitals
    • Palmoplantar hyperhidrosis and hyperkeratosis
    • Loss of dermatoglyphs
    • Frictional bullae
    • Acrocyanosis
    • Premature graying of the hair
  • Nail dystrophy
    • Present during early childhood
    • Initial changes: longitudinal ridging and splitting, followed by pterygia formation, and occasionally complete nail loss
  • Oral
    • Pre-malignant leukoplakia, usually occurring in early adolescence
    • White plaques have predilection for lateral portion of tongue
    • Can have involvement of urethra, vagina and anus
    • Can have teeth malformation, missing, aberrant spacing or extensive caries
  • Extra-cutaneous
    • Epiphora: continuous lacrimation due to lacrimal duct atresia
    • Bone marrow failure: 50-90%, major cause of mortality
      • Second-third decade
      • Anaemia, thrombocytopaenia, pancytopaenia
    • Malignancies:
      • Third-fourth decade
      • SCCs in mouth, anus, cervix, vagina, oesophagus, skin’
      • Increased risk of myelodysplastic syndrome, AML and GI carcinomas
    • Other
      • Pulmonary fibrosis
      • Liver cirrhosis
      • Developmental delay
      • Short stature
      • Avascular necrosis of the femoral head
      • Oesophageal or urethral stenosis
      • Cryptorchidism
      • Male hypogonadism
      • Immunologic dysfunction leading to opportunistic infection

Can diagnose with FISH

32
Q

Dowling Degos mutation

A

KRT5

33
Q

Dowling Degos clinical

A
  • Third-fourth decade of life
  • Reticulated hyperpigmentation with sometimes lentigo-like brown macules, small brown papules with variable hyperkeratosis
  • Findings progressively increased over time
  • Start in axillae and groin, followed by intergluteal and inframammary folds, neck, trunk, inner aspect of arms and thighs
  • Pruritis can occur
  • Comedone-like lesions on the back or neck, pitted perioral scars, epidermoid cysts and HS represent additional features

Dermnet says:

  1. Hyperpigmentation
  2. Follicular papules
  3. Hypopigmented macules and papules
  4. Comedones predominantly to neck
  5. Scar

Associations:

  • HS
  • SCCs and KAs
  • Nail dystrophy
  • Seb Ks
  • Cysts
34
Q

Dowling Degos histology

A
  • Increased pigmentation of the basal layer and finger-like elongation of the rete ridges within thinning of the suprapapillary epithelium - antler like pattern
  • Dermal melanophages, mild perivascular lymphohistiocytic infiltrate
  • Galli-Galli disease - variant, suprabasal non-dyskeratotic acantholysis of lesional skin, also KRT5 mutation
35
Q

Dowling Degos treatment

A

No successful treatmentsTopical steroids, retinoids, azelaic acid
Er:Yag

Derm (57 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions